Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Protara Therapeutics (TARA)
NASDAQ:TARA
Protara Therapeutics (TARA) Stock Price & Analysis
216 Followers
TARA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.38 - $4.60
Previous Close$2.85
Volume13.19K
Average Volume (3M)37.06K
Market Cap
$32.23M
Enterprise Value-$48.22M
Total Cash (Recent Filing)$86.61M
Total Debt (Recent Filing)$6.16M
Price to Earnings (P/E)-0.5
Beta1.51
Next Earnings
Aug 07, 2023EPS Estimate
-$0.87Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-5.70
Shares Outstanding11,307,962
10 Day Avg. Volume43,258
30 Day Avg. Volume37,059
Standard Deviation0.29
R-Squared0.04
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)0.39
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-2.84K
Enterprise Value/Gross Profit-2.84K
Enterprise Value/Ebitda1.11
Forecast
1Y Price Target
$23.00Price Target Upside707.02% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Protara Therapeutics News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
TARA FAQ
What was Protara Therapeutics’s price range in the past 12 months?
Protara Therapeutics lowest stock price was $2.38 and its highest was $4.60 in the past 12 months.
What is Protara Therapeutics’s market cap?
Currently, no data Available
When is Protara Therapeutics’s upcoming earnings report date?
Protara Therapeutics’s upcoming earnings report date is Aug 07, 2023 which is in 60 days.
How were Protara Therapeutics’s earnings last quarter?
Protara Therapeutics released its earnings results on May 04, 2023. The company reported -$0.8 earnings per share for the quarter, beating the consensus estimate of -$0.877 by $0.077.
Is Protara Therapeutics overvalued?
According to Wall Street analysts Protara Therapeutics’s price is currently Undervalued.
Does Protara Therapeutics pay dividends?
Protara Therapeutics does not currently pay dividends.
What is Protara Therapeutics’s EPS estimate?
Protara Therapeutics’s EPS estimate is -$0.87.
How many shares outstanding does Protara Therapeutics have?
Protara Therapeutics has 11,307,962 shares outstanding.
What happened to Protara Therapeutics’s price movement after its last earnings report?
Protara Therapeutics reported an EPS of -$0.8 in its last earnings report, beating expectations of -$0.877. Following the earnings report the stock price went down -1.294%.
Which hedge fund is a major shareholder of Protara Therapeutics?
Among the largest hedge funds holding Protara Therapeutics’s share is Perceptive Advisors LLC. It holds Protara Therapeutics’s shares valued at 908K.
---
Protara Therapeutics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-17.86%
12-Months-Change
Fundamentals
Return on Equity
-52.02%
Trailing 12-Months
Asset Growth
-34.01%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Protara Therapeutics
ArTara Therapeutics, Inc. is a clinical-stage company engages in developing treatments for rare and specialty diseases with significant unmet needs. Its current development programs focus on the treatment of rare diseases in structural and connective tissues and rare hepatology, gastrointestinal, and metabolic disorders. The company was founded by Jesse Shefferman in 2017 and is headquartered in New York, NY.
---
Top 5 ETFs holding TARA
iShares Core S&P Total U.S. Stock Market ETF
$11.33K
Up to five ETFs with an Outperform Smart Score that hold TARA. The ETFs are listed according to market value of TARA within the ETF
---
---